GLP-1 Medicines and Imaginative and prescient Loss: What You Have to Know

Jessi Macdonald was scrolling via social media when she noticed a publish about GLP-1 medicines and an elevated danger of imaginative and prescient loss.

“I referred to as my physician instantly,” she stated. Macdonald is likely one of the near 21 million girls within the U.S. taking a GLP-1. She stated the burden loss treatment has changed her life, and he or she didn’t wish to cease taking it. However the headline gave her pause.

In early November, the Food and Drug Administration (FDA) introduced it was requiring all producers of GLP-1s so as to add the potential elevated danger of nonarteritic anterior ischemic optic neuropathy (NAION) — an eye fixed situation that causes imaginative and prescient loss — to the warning labels on the medicines.

So must you be involved about your eye well being if you happen to’re taking a GLP-1? Right here’s what you’ll want to learn about NAION and what to bear in mind concerning your eye well being and GLP-1s.

What’s NAION?

Nonarteritic anterior ischemic optic neuropathy (NAION) is an eye fixed situation that causes painless, sudden imaginative and prescient loss in a single eye.

NAION occurs when there’s a sudden blockage or discount of blood movement to the entrance a part of the optic nerve, also referred to as the optic disk. “It is principally having a small stroke within the eye,” stated Karen Allison M.D., affiliate professor of ophthalmology on the College of Rochester Flaum Eye Institute and board member of the Stop Blindness group.

NAION occurs with out warning — most individuals discover the change after waking up within the morning — and the imaginative and prescient loss is normally everlasting.

The excellent news is that NAION is a uncommon situation. “The chance is low — it doesn’t matter if you happen to take a GLP-1 or not,” Allison stated. “The chance is highest in individuals who have underlying vascular danger elements akin to diabetes, hypertension, sleep apnea, a crowded optic disc and are of older age.”

What led to the NAION warning on GLP-1 medicines?

The FDA not too long ago analyzed a number of research to have a look at the affiliation between NAION and GLP-1 medicines.

A meta-analysis of 126 trials discovered that individuals who have been prescribed the GLP-1 semaglutide for Kind 2 diabetes or obesity confirmed potential elevated danger for NAION in comparison with the individuals who took totally different antidiabetic or weight reduction medicines. The estimated fee was 6.4 circumstances per 100,000 folks taking a GLP-1 drug in comparison with 3.8 circumstances for folks taking a placebo or non-GLP-1 diabetes treatment.

One other examine, a 2025 analysis of 37.1 million folks with Kind 2 diabetes, additionally discovered an elevated danger related to taking the GLP-1 semaglutide in comparison with different glucose-lowering medicines.

However the important thing phrase within the analysis is affiliation. “The affiliation is regarding sufficient that it warrants additional examine, clearly, but it surely’s necessary that we stress that an affiliation doesn’t essentially show causation,” Allison stated. “Researchers are nonetheless attempting to find out if the treatment contributes to NAION or is it due to the underlying circumstances. The FDA warning is simply to let folks pay attention to the affiliation.”

Exterior of NAION, some studies have discovered an affiliation between GLP-1s and eye circumstances akin to worsening diabetic retinopathy, macular edema, vitreous hemorrhages and adjustments in imaginative and prescient, however analysis is ongoing as to the impact GLP-1s might have on eye well being.

GLP-1s and eye well being

We do know that GLP-1 medicines are primarily prescribed for folks dwelling with Kind 2 diabetes and weight problems, and each circumstances can have an effect on eye health.

For folks with Kind 2 diabetes, excessive blood sugar ranges can injury the tissues and blood vessels within the eyes and trigger imaginative and prescient loss. In reality, diabetes is the main reason for blindness for folks ages 18 to 64.

Relating to weight problems, Allison famous that folks dwelling with the illness are at elevated danger for diabetes and different circumstances like hypertension and sleep apnea — all of which might have an effect on the vascular system and trigger eye injury.

So, when you have diabetes or weight problems or one other situation that GLP-1 medicines are prescribed for, it’s necessary to get an eye exam a minimum of annually to search for any issues.

A complete eye examination can even present when you have a crowded optic disc, also referred to as a “disk in danger,” which might improve the danger for NAION. “As a result of there are not any signs of NAION, you wish to get proactive therapy or analysis,” Allison stated.

For most individuals, taking a GLP-1 treatment helps deal with underlying causes which might be dangerous to eye well being. However how GLP-1s might have an effect on eye well being long-term continues to be being studied. “We don’t need folks to be afraid and never take GLP-1 medicines, but it surely’s crucial for folks to know if they’ve any adjustments to get their imaginative and prescient checked instantly,” Allison stated.